Slate Path Capital LP Viatris Inc Transaction History

Slate Path Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$11.27 - $13.53 $50 Million - $60 Million	-4,438,000 Reduced 29.13%	10,798,000 $129 Million
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $90.2 Million - $112 Million	10,287,000 Added 207.86%	15,236,000 $165 Million
Q3 2023 Nov 14, 2023	SELL	$9.59 - $11.35 $27.5 Million - $32.6 Million	-2,872,000 Reduced 36.72%	4,949,000 $48.8 Million
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $70.5 Million - $80.5 Million	7,821,000 New	7,821,000 $78.1 Million
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $143 Million - $174 Million	-11,835,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $169 Million - $222 Million	11,835,000 New	11,835,000 $222 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Slate Path Capital LP, based on Form 13F filings with the SEC.

Stay updated on Slate Path Capital LP with notifications on news.